Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 15, 2018 08:00 ET | Source: Spectral Medical Inc.

Spectral Announces Health Canada Approval of Its Proprietary Stand-Alone Pump for CRRT and Hemoperfusion

TORONTO, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc., (TSX:EDT), a Phase III company developing a treatment for patients with endotoxemic septic shock, today announced that Health Canada...
February 01, 2018 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical Announces the Appointment of Chief Financial Officer

TORONTO, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc., (TSX:EDT), a Phase III company developing a treatment for patients with endotoxemic septic shock, today announced that Richard...
December 18, 2017 08:00 ET | Source: Spectral Medical Inc.

FDA Grants 510(k) Clearance for Spectral's Proprietary Stand-Alone Pump

TORONTO, ONTARIO--(Marketwired - Dec. 18, 2017) - Spectral Medical Inc., (TSX:EDT), a Phase III company developing the first treatment for patients with septic shock guided by a companion...
December 13, 2017 08:00 ET | Source: Spectral Medical Inc.

Spectral to Launch Toraymyxin(TM)/EAA(TM) in Canada in Q1 2018

TORONTO, ONTARIO--(Marketwired - Dec. 13, 2017) - Spectral Medical Inc., (TSX:EDT), a Phase III company developing the first treatment for patients with septic shock guided by a companion...
November 14, 2017 08:00 ET | Source: Spectral Medical Inc.

Spectral Announces Third Quarter Results

TORONTO, ONTARIO--(Marketwired - Nov. 14, 2017) - Spectral Medical Inc., (TSX:EDT), a Phase III company developing the first treatment for patients with endotoxemic septic shock, today...
October 31, 2017 08:00 ET | Source: Spectral Medical Inc.

Spectral Provides Update on FDA Meeting Regarding Its PMA Submission for Toraymyxin(TM)

TORONTO, ONTARIO--(Marketwired - Oct. 31, 2017) - Spectral Medical Inc., (TSX:EDT), a Phase III company developing the first treatment for patients with endotoxemic septic shock, today...
October 18, 2017 08:00 ET | Source: Spectral Medical Inc.

Spectral Announces Retirement of Chief Financial Officer

TORONTO, ONTARIO--(Marketwired - Oct. 18, 2017) - Spectral Medical Inc. ("Spectral" or the "Company") (TSX:EDT) a Phase III Company advancing a precision treatment targeting specific...
October 04, 2017 12:10 ET | Source: Spectral Medical Inc.

Spectral Presents Key EUPHRATES Trial Data at the Canadian Critical Care Forum

TORONTO, ONTARIO--(Marketwired - Oct. 4, 2017) - Spectral Medical Inc., (TSX:EDT), a Phase III company developing the first treatment for patients with endotoxemic septic shock, announced...
September 21, 2017 08:00 ET | Source: Spectral Medical Inc.

Spectral Provides Regulatory Update on Its PMA Submission for Toraymyxin(TM)

TORONTO, ONTARIO--(Marketwired - Sept. 21, 2017) - Spectral Medical Inc., (TSX:EDT), a Phase III company developing the first treatment for patients with endotoxemic septic shock, today...
August 11, 2017 08:00 ET | Source: Spectral Medical Inc.

Spectral Announces Second Quarter Results

TORONTO, ONTARIO--(Marketwired - Aug. 11, 2017) - Spectral Medical Inc., (TSX:EDT), a Phase III company developing the first treatment for patients with septic shock, today announced its...